112 related articles for article (PubMed ID: 17498700)
1. Manifold active-state conformations in GPCRs: agonist-activated constitutively active mutant AT1 receptor preferentially couples to Gq compared to the wild-type AT1 receptor.
Lee C; Hwang SA; Jang SH; Chung HS; Bhat MB; Karnik SS
FEBS Lett; 2007 May; 581(13):2517-22. PubMed ID: 17498700
[TBL] [Abstract][Full Text] [Related]
2. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
[TBL] [Abstract][Full Text] [Related]
3. The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.
Auger-Messier M; Clement M; Lanctot PM; Leclerc PC; Leduc R; Escher E; Guillemette G
Endocrinology; 2003 Dec; 144(12):5277-84. PubMed ID: 12960024
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin (1-7) does not interact directly with MAS1, but can potently antagonize signaling from the AT1 receptor.
Gaidarov I; Adams J; Frazer J; Anthony T; Chen X; Gatlin J; Semple G; Unett DJ
Cell Signal; 2018 Oct; 50():9-24. PubMed ID: 29928987
[TBL] [Abstract][Full Text] [Related]
5. Site-specific cleavage of G protein-coupled receptor-engaged beta-arrestin. Influence of the AT1 receptor conformation on scissile site selection.
Lee C; Bhatt S; Shukla A; Desnoyer RW; Yadav SP; Kim M; Jang SH; Karnik SS
J Biol Chem; 2008 Aug; 283(31):21612-20. PubMed ID: 18505723
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of constitutive activation of the AT1 receptor: influence of the size of the agonist switch binding residue Asn(111).
Feng YH; Miura S; Husain A; Karnik SS
Biochemistry; 1998 Nov; 37(45):15791-8. PubMed ID: 9843384
[TBL] [Abstract][Full Text] [Related]
7. Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways.
Pang HW; Linares A; Couling L; Santollo J; Ancheta L; Daniels D; Speth RC
Endocrine; 2019 Nov; 66(2):349-359. PubMed ID: 31020463
[TBL] [Abstract][Full Text] [Related]
8. Agonist-dependent internalization of the angiotensin II type one receptor (AT1): role of C-terminus phosphorylation in recruitment of beta-arrestins.
Kule CE; Karoor V; Day JN; Thomas WG; Baker KM; Dinh D; Acker KA; Booz GW
Regul Pept; 2004 Aug; 120(1-3):141-8. PubMed ID: 15177932
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the fate of type I angiotensin receptor after biased activation.
Szakadáti G; Tóth AD; Oláh I; Erdélyi LS; Balla T; Várnai P; Hunyady L; Balla A
Mol Pharmacol; 2015 Jun; 87(6):972-81. PubMed ID: 25804845
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone stimulates beta-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor.
Tilley DG; Nguyen AD; Rockman HA
Biochem Biophys Res Commun; 2010 Jun; 396(4):921-6. PubMed ID: 20460106
[TBL] [Abstract][Full Text] [Related]
11. A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology.
Balakumar P; Jagadeesh G
Cell Signal; 2014 Oct; 26(10):2147-60. PubMed ID: 25007996
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of constitutive activity: mutations at position 111 of the angiotensin AT1 receptor.
Nikiforovich GV; Mihalik B; Catt KJ; Marshall GR
J Pept Res; 2005 Nov; 66(5):236-48. PubMed ID: 16218991
[TBL] [Abstract][Full Text] [Related]
13. Single mutations at Asn295 and Leu305 in the cytoplasmic half of transmembrane alpha-helix domain 7 of the AT1 receptor induce promiscuous agonist specificity for angiotensin II fragments: a pseudo-constitutive activity.
Feng YH; Zhou L; Qiu R; Zeng R
Mol Pharmacol; 2005 Aug; 68(2):347-55. PubMed ID: 15901848
[TBL] [Abstract][Full Text] [Related]
14. The active and the inactive form of the hAT1 receptor have an identical ligand-binding environment: an MPA study on a constitutively active angiotensin II receptor mutant.
Clément M; Chamberland C; Pérodin J; Leduc R; Guillemette G; Escher E
J Recept Signal Transduct Res; 2006; 26(5-6):417-33. PubMed ID: 17118790
[TBL] [Abstract][Full Text] [Related]
15. The active state of the AT1 angiotensin receptor is generated by angiotensin II induction.
Noda K; Feng YH; Liu XP; Saad Y; Husain A; Karnik SS
Biochemistry; 1996 Dec; 35(51):16435-42. PubMed ID: 8987975
[TBL] [Abstract][Full Text] [Related]
16. The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II.
Billet S; Bardin S; Tacine R; Clauser E; Conchon S
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E840-8. PubMed ID: 16332920
[TBL] [Abstract][Full Text] [Related]
17. Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT
Teixeira LB; Parreiras-E-Silva LT; Bruder-Nascimento T; Duarte DA; Simões SC; Costa RM; Rodríguez DY; Ferreira PAB; Silva CAA; Abrao EP; Oliveira EB; Bouvier M; Tostes RC; Costa-Neto CM
Sci Rep; 2017 Sep; 7(1):11903. PubMed ID: 28928410
[TBL] [Abstract][Full Text] [Related]
18. Conformational induction is the key process for activation of the AT1 receptor.
Ellis J; Warburton P; Donnelly D; Balmforth AJ
Biochem Pharmacol; 2006 Feb; 71(4):464-71. PubMed ID: 16343447
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity.
Domazet I; Holleran BJ; Richard A; Vandenberghe C; Lavigne P; Escher E; Leduc R; Guillemette G
Mol Pharmacol; 2015 Jun; 87(6):982-95. PubMed ID: 25808928
[TBL] [Abstract][Full Text] [Related]
20. The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells.
Auger-Messier M; Turgeon ES; Leduc R; Escher E; Guillemette G
Exp Cell Res; 2005 Aug; 308(1):188-95. PubMed ID: 15896777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
